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disrupt either the monkey’s
performanceonthetrainedtaskor its
normal behaviour in the home cage.
Over several days of conditioning,
the torque direction of recording site
effects shifted towards the direction
ofstimulationsiteeffects.Theeffects
from a third, control (Ctrl) electrode
did not change.Recordingofmuscle
EMG confirmed that, after
conditioning with the artificial
connection, new muscles were
activated by intracortical
microstimulation at the recording
site, which had previously only been
activated from the stimulation site. In
somecases, changeswerestable for
up to a week after the end of
conditioning. The basic result was
confirmed in 13 out of 17 tests
carried out in two monkeys.
In a further sequence of
experiments, Jackson et al. [1]
established that these changes
occurred only when stimulation
followed spike activity by up to
50 milliseconds: longer delays or
fixed frequency stimulation did not
produce the same conditioned
changes. The authors interpret
these changes as arising from the
coincidence of stimulus-evoked
activity (at the stimulation site) with
synchronousfiringofneurons (at the
recording site) inducing plasticity in
horizontal or descending motor
pathways. Neurons that are
synchronizedat thecortical level are
known to share common outputs
[4], and the conditioning stimuli may
have increased such synchrony.
The fact that conditioning was
absent unless stimuli were closely
time-locked to spike events
suggests that the underlying
mechanismmaybe related to spike-
timing dependent plasticity, which
haspreviouslybeendescribedat the
cellular level [5]. The experiments
demonstrate that natural patterns of
cortical spiking in vivoduring normal
behaviour can lead to input-specific
Hebbian plasticity when paired with
stimulation at a second site. These
plastic changes probably occur at
multiple levels, involving not only
shortand long-distanceconnections
within the cortex [6] but also at
subcortical sites and in pathways
descending to the spinal cord.
The potential for plastic change
within the motor cortex was first
recognized nearly a century ago by
Sherrington and Brown [7]. The
plasticity of the primary motor
cortex (M1) output is undoubtedly
of great importance for adaptive
motor learning in primates, and
particularly humans, a capacity that
is essential for sophisticated
behaviors as diverse as the
manufacture and use of tools, sport
and music making. This plasticity
has been shown to be strongly
influenced by motor learning,
use-dependence and sensory
stimulation [8]. It is also
fundamental to modern ideas of
neurorehabilitation and the
compensatory changes that occur
in the injurednervous system [9,10].
As evidenced by the recent
Society for Neuroscience meeting
in Atlanta, the brain–machine
interface field is now a massive
multimillion dollar enterprise. Many
labs are working on artificial
connections that could form the
basis of a neural prosthesis to
replace neural pathways lost
through injury or disease, such as
after spinal cord injury or stroke.
The Neurochip used by Jackson
et al. [1] linksmotor cortex sites just
a few millimeters apart, but it could
be adapted for much longer
interactions, linking, for example,
motor cortex to spinal cord or
peripheral nerve severed from
supraspinal control by injury. But in
addition, the new results suggest
that such a prosthesis could have
additional rehabilitative roles
in cases of partial injury by
strengthening surviving projections
between connected sites. This type
of approachmight for instancebeof
considerable relevance for
restoring further function topatients
with incompletespinal lesions; such
patients constitute the majority of
the spinal cord injured community.
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R55Neurodegeneration: Nicked
to Death
Ataxia oculomotor apraxia-1 is a neurological disorder that arises from
mutations in the gene encoding the protein aprataxin. A recent study
demonstrates that aprataxin is critical for the processing of obstructive
DNA termini, suggesting a broader role for DNA single-strand break
repair in neurodegenerative disease.David M. Wilson, III1,*
and Mark P. Mattson2
Neurons are postmitotic cells that
must survive and function properly
for the entire lifetime of the
organism. Because they cannot bereplaced and are subjected to high
metabolic stress, mechanisms for
coping with damaged molecules
may be particularly important in
these cells. Indeed, human
neurodegenerative disorders, such
as Alzheimer’s and Parkinson’s
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Figure 1. Outcomes of failed repair of non-conventional 30- or 50-obstructive ends.
Trapped 30-TOPO1–DNA intermediates (blue circle, within red box) can arise from
stalled TOPO1 reactions. 30-phosphate (P) and -phosphoglycolate (PG) damages are
products of free radical attack of DNA. In some instances, abasic (AP) sites are cleaved
by multifunctional DNA glycosylases, which can generate 30-P or 30-unsaturated alde-
hyde (UA) residues. 50-AMP groups (blue lettering, within red box) are produced by
failed DNA ligase reactions. On occasion, free radical attack of DNA can leave behind
50-OH ends. 50-dRP residues are generated by incision of DNA by an abasic endonucle-
ase. Themajor enzymes for excising terminal damages or for restoring conventional ter-
mini are denoted. After termini ‘clean-up’, typical SSB repair proceeds via gap-filling by
DNAPolb, and sealing of the nick by anXRCC1–LIG3a complex. In cells deficient for SSB
repair, as a result of genetic mutations (AOA1 and SCAN1) or age-related disease, SSBs
accumulate. In non-dividing cells, such as neuronal tissue, accumulation of SSBs leads
to impaired transcription,which in turn leads tocell death. In dividing cells, SSBsare con-
verted to double-strand breaks upon replication fork collapse, and these double-strand
break intermediates are repaired efficiently and accurately by a nuclease-dependent ho-
mologous recombination (HR) pathway. Although themolecular details are presently un-
certain (shown as ?), for the removal of 30-blocking termini during HR, the ERCC1/XPF
complex is apossible nuclease,while the flapendonucleases FEN1orEXO1arepotential
enzymes for processing 50-blocking termini.diseases, involve the abnormal
accumulation of damaged proteins
[1], and other syndromes, such as
ataxia telangiectasia (AT), have
been associated with defects in
DNA-damage processing [2].
Work from El-Khamisy et al. [3]
and a more recent study by
Ahel et al. [4] have revealed
that inefficient repair of DNA
single-strand breaks (SSBs) can
give rise to neurodegenerative
disease, in particular,
spinocerebellar ataxia with axonal
neuropathy-1 (SCAN1) and ataxia
oculomotor apraxia-1 (AOA1),
respectively. These data provide
evidence that non-replicating,
post-mitotic neurons are
particularly sensitive to the
accumulation of DNA SSBs.SSBs, one of the most common
lesions formed in chromosomal
DNA, are generated by the attack
of reactive oxygen species [5] or
as natural intermediates during
certain DNA transactions, including
repair and replication [6]. In both
instances, SSBs can harbor
non-conventional 30 or 50 termini,
such as phosphates,
phosphoglycolates, or trapped
polypeptides, which present
obstacles to polymerization and
ligation activities. To remove such
obstructions, cells undergo SSB
repair, a process related to the
more classical base excision
repair (BER) pathway [7]. The SSB
repair proteins excise terminal
blocking groups (Figure 1),
permitting gap-filling synthesisand sealing of the final nick in
DNA.
AOA1 and SCAN1 are hereditary
autosomal recessive ataxias
affecting primarily motor
coordination, i.e. gaze, speech,
gait and balance [8–10]. Unlike
patients suffering from other
DNA-repair-related disorders
characterized by neurological
dysfunction, such as AT [2],
patients suffering from AOA1 and
SCAN1 lack non-neurological
symptoms, most notably the
increased cancer incidence. The
recent cloning and characterization
of the genes defective in AOA1 and
SCAN1 has shed light on why
non-replicating neuronal cells may
be exquisitely sensitive to the
accumulation of certain DNA
intermediates.
The gene mutated in SCAN1
encodes the protein tyrosyl-DNA
phosphodiesterase 1 (TDP1) [8],
which was shown to be the primary
enzyme for excising covalently
linked 30-topoisomerase I
(TOPO1) –DNA intermediates [11].
TOPO1 binds and cleaves one
strand of DNA via a transient
covalent protein–nucleic acid
complex to relieve topological
strains (i.e. supercoils) generated
during repair, replication or
recombination. However, the
TOPO1–DNA intermediate can
become ‘trapped’ either when in
close proximity to DNA damage,
such as oxidative lesions, or upon
exposure of cells to the
chemotherapeutic agent
camptothecin [6]. TDP1 removes
the covalently linked 30-TOPO1
protein moiety, leaving behind a
30-phosphate group, which is
excised by polynucleotide
kinase/phosphatase (PNKP) [3].
These enzymatic steps generate
a normal 30-hydroxyl end, which is
suitable for polymerase extension
and subsequent ligation. The
studies of El-Khamisy et al. [3]
indicate that cells from SCAN1
patients are unable to process
specific 30-obstructive termini
efficiently.
El-Khamisy and colleagues [3]
found that SCAN1 cells are
defective in the repair of
camptothecin-induced SSBs that
arise independently of DNA
replication. Moreover, the authors
report that TDP1 directly interacts
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a partner of the SSB repair protein
XRCC1, and exists in a complex
with LIG3a, XRCC1, and PNKP
that is capable of repairing
tyrosyl-containing oligonucleotide
substrates that mimic TOPO1–DNA
SSBs. While a similar multi-protein
complex was found in extracts
from SCAN1 cells, the
disease-causing TDP1 mutations
render the phosphodiesterase
incapable of excising 30-tyrosyl
blocking groups from DNA [3,8].
It was postulated that the
accumulation of obstructive
30-terminal SSBs would impair
transcriptional efficacy and induce
cell death.
Ahel and colleagues [4] have now
expanded the concept that defects
in SSB repair can lead selectively to
neuronal cell death. The gene
defective in AOA1 encodes the
protein aprataxin, which contains
three conserved domains: a
forkhead-associated interaction
module; a histidine triad (HIT)
domain found in nucleotide
hydrolases and transferases; and
a DNA-binding C2H2 zinc-finger
motif [9,10]. While prior
investigations had revealed
interactions of aprataxin with
proteins involved in SSB repair,
namely XRCC1 and
poly(ADP-ribose) polymerase 1
(PARP1) [12,13], a biochemical
activity for aprataxin in this repair
response had not been identified.
Ahel and colleagues [4],
recognizing that the
aprataxin-binding proteins XRCC1
and XRCC4 are stable interaction
partners of DNA ligases [13],
examined whether aprataxin might
release 50-AMP intermediates that
remain after failed ligation
reactions. Indeed, recombinant
aprataxin was found to excise AMP
residues linked to the 50-terminal
phosphate group of synthetic DNA
substrates, a step necessary for
subsequent repair events in vitro.
In addition, vertebrate cell extracts
lacking aprataxin, including those
from AOA1 lymphoblastoid cells,
were defective in the removal of
DNA-adenylates formed by
abortive ligation reactions, which
occur more frequently at
non-conventional oxidative SSBs.
The authors propose that the
inability of aprataxin to act as anAMP-hydrolase results in the
accumulation of DNA strand
breaks that ultimately impair
normal cellular physiology and lead
to neuronal cell death. Notably, the
disease-causing mutations in
APTX are truncating and missense
in nature, and are largely confined
to the HIT domain [9,10].
The current data leave two key
issues unresolved. First, why do
AOA1 and SCAN1 DNA repair
defects lead to neurological
dysfunction, yet not cancer
susceptibility? One possibility is
that non-dividing cells accumulate
SSBs, which ultimately lead to
impaired transcriptional
programming and eventual cell
death (Figure 1). Indeed, SSBs are
effective blocks to RNA
polymerase progression [14].
Furthermore, due to their unusually
high rates of oxygen metabolism,
neuronal cells probably
accumulate more trapped
30-TOPO1 and 50-AMP
intermediates due to the
production of oxidative DNA
damage. Conversely, in dividing
cells, unrepaired SSBs would give
rise upon replication fork collapse
to DNA double-strand breaks,
which would presumably be
efficiently and accurately repaired
by homologous recombination
(Figure 1). Thus, while a broad
range of DNA intermediates can
drive neuronal cell loss and
neurodegenerative disease, the
SSBs of AOA1 and SCAN1 are
apparently not particularly
mutagenic in replicating tissue,
unlike the double-strand breaks
associated with AT and Nijmegen
breakage syndrome, or the bulky,
helix-distorting lesions found in
xeroderma pigmentosum, or the
unresolved complex DNA
structures in Fanconi anemia,
Werner syndrome, Bloom
syndrome and Rothmund
Thomson syndrome [2]. Future
studies need to address
specifically whether SSBs in fact
accumulate in the neuronal cells
of AOA1 and SCAN1 patients.
Interestingly, individuals suffering
from the disorder Cockayne
syndrome are also not
cancer-prone, yet exhibit gross
developmental abnormalities and
neurological deficits [15]. A defect
in facilitating transcription orrepairing endogenous DNA
damage, or both, may be
responsible for the selective loss
of neuronal tissue in this disease.
Second, is it a general feature
that defects in SSB repair lead to
enhanced neuronal cell death?
Mice devoid of the major gap-filling
DNA polymerase, Polb, exhibit
defective neurogenesis
characterized by apoptotic cell
death in the developing central and
peripheral nervous systems that
ultimately leads to neonatal
lethality [16]. Model systems
impaired in other SSB repair steps
could also be examined to
interrogate this hypothesis further.
For instance, XRCC1 is a
non-enzymatic scaffold protein
that facilitates efficient BER/SSB
repair [7], so deficiencies in this
protein should lead to increased
neuronal cell death, and
accompanying neurological
dysfunction. Defects in PNKP,
which as noted above operates in
the same pathway as TDP1, should
likewise result in increased
neurological deficits. Suggestive of
a role for these proteins in
maintaining neuronal cell viability is
the fact that camptothecin-induced
strand breaks accumulate in
XRCC1-deficient CHO cells and in
PNKP-depleted human A549 cells
at levels similar to those detected
in SCAN1 cells [3]. Whether or not
deficits in these repair proteins will
strictly affect neurodegeneration,
and not cancer susceptibility,
awaits investigation. In this regard,
it is noteworthy that defects in the
strand break response protein,
PARP1, lead to both neurological
abnormalities and cancer
predisposition in mouse models
[17]. Finally, there is emerging
evidence that defects in the core
BER participants, i.e. some of the
DNA glycosylases, which remove
endogenous base modifications,
and the abasic (AP) endonuclease
APE1, which initiates excision of
AP sites in DNA as well as certain
30-damages, contribute to neuronal
cell survival, at least in culture [18].
We close by mentioning a few
considerations relevant to the
discussion above. First, DNA repair
systems differ qualitatively and
quantitatively between dividing
and non-dividing cells [19]. In
particular, global DNA repair
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differentiated neurons, whereas
the machinery for repairing
transcribed sequences is
maintained or upregulated.
Second, perturbations in DNA
repair more subtle than those
caused by genetic mutations may
contribute to the demise of
neurons in age-related disorders
such as Alzheimer’s disease [20].
It will be of particular importance
now to determine the influence of
both dramatic and subtle variation
in the different DNA-damage
responses, particularly the SSB
repair processing enzymes
(Figure 1), as well as environmental
factors, such as diet and lifestyle,
on the susceptibility of neurons
during aging.
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When playing lotto, you show
a certain risk-proneness, as you
prefer to invest money into
a gamble whose actual outcome is
uncertain, instead of using that
money to buy a commodity that
you could obtain with certainty. On
the other hand, when hesitating to
contract a retirement plan, you
prefer using your budget to afford
things that you fancy today,
instead of investing it to obtain
benefits that are yet to come.
These scenarios exemplify two
classes of decision making that are
extensively discussed in the choice
literature: decisions under risk, and
inter-temporal decisions. The first
class, decisions under risk, involve
choosing between an option with
